期刊文献+

充血性心力衰竭患者的血浆一氧化氮改变及意义 被引量:1

THE LEVEL OF PLASMA NITRIC OXIDE AND ITS SIGNIFICANCE IN PATIENTS WITH CONGESTIVE HEART FAILURE
原文传递
导出
摘要 为探讨充血性心力衰竭(CHF)患者的血浆一氧化氮(NO)含量及其意义,本文采用比色分析法测定了42例CHF患者的血浆NO浓度,结果发现,CHF患者的血浆NO(64.47±21.42μmol/L)显著高于对照组(51.62±13.62μmol/L),P<0.005,其中心功能Ⅲ~Ⅳ级(按NYHA心功能分级标准)患者的血浆NO(78.8±10.85μmol/L)显著高于心功能Ⅱ组者(53.77±11.79μmol/L),P<0.001。提示CHF患者的血浆NO水平增高,NO在CHF的发生发展中起重要作用,且与病情严重程度相关。 In order to study the level of plasma nitric oxide (NO) and its significance in patients with congestive heart failure (CHF), the plasma NO was measured in 42 patients with CHF by colorimetric analysis. The results showed that the level of plasma NO was significantly higher in patients with CHF (64. 47± 21.42μmol/L)than that in controls (51. 62± 13. 62μmol/L), P<0. 005, and in which the level of plasm NO was significantly higher in NYHA functional class Ⅲ ~ Ⅳ (78. 28± 10. 85μmol/L) than that in class Ⅱ (53. 77± 11. 79μmol/l), P<0. 001. The results indicated that there was a increased level of plasma NO in CHF. The plasma NO plays an important role in the development of CHF and the level of NO was associated with the degree of CHF.
机构地区 解放军第 解放军第
出处 《急诊医学》 CSCD 1998年第1期37-38,共2页
关键词 充血性心力衰竭 一氧化氮 血浆 Congestive heart failure Nitric oxide
  • 相关文献

同被引文献8

  • 1王江 祝善俊 祝善俊 徐成斌 主编.神经激素受体与心力衰竭[A].祝善俊,徐成斌,主编.心力衰竭基础与临床.第1版[C].北京:人民军医出版社,2001.90.
  • 2Moniotte S, Kobzik L, Feron O. et al. Upregulation of β3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation, 2001, 103 (12): 1649-1655.
  • 3Teerlink JR, Pfeffer JM, Pfeffer MA. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats.Circ Res, 1994, 75 (1): 105-113.
  • 4Dincer UD, Bidasee KR, Guner S, et al. The effect of diabetes on expression of β1 -, β2-, and β3-adrenoreceptors in rat hearts. Diabetes,2001, 50 (2): 455-461.
  • 5Gauthier C, Leblais V, Kobzik L, et al. The negative inotropic effect of β3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest, 1998, 102 (7):1377-1384.
  • 6Heymes C, Vanderheyden M, Bronzwaer JG, et al. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation, 1999, 99 (23): 3009-3016.
  • 7Engelhardt S, Bohm M, Erdmann E, et al. Analysis of β-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of β 1-adrenergic receptor mRNA in heart failure. J Am Coll Cardiol, 1996, 27(1): 146-154.
  • 8Chantal G, Dominique L, JeanL B. β3-adrenoceptors in the cardiovascular system. Trend Phama Science, 2000, 21 (2): 426-431.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部